A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)

NCT02015312 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Light Chain (AL) Amyloidosis
Cardiac Involvement

Interventions

DRUG: Epigallocatechin-3-gallate (EGCG)
DRUG: Placebo

Sponsor

Florian Michel

Collaborators

[object Object]